Wells Fargo’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-207,270
Closed -$871K 7444
2023
Q1
$871K Buy
+207,270
New +$871K ﹤0.01% 3253
2022
Q4
Sell
-7,426
Closed -$43K 7600
2022
Q3
$43K Buy
7,426
+1,575
+27% +$9.12K ﹤0.01% 4719
2022
Q2
$35K Buy
5,851
+5,351
+1,070% +$32K ﹤0.01% 4918
2022
Q1
$2K Sell
500
-17
-3% -$68 ﹤0.01% 6380
2021
Q4
$1K Buy
517
+1
+0.2% +$2 ﹤0.01% 6588
2021
Q3
$2K Sell
516
-27
-5% -$105 ﹤0.01% 6301
2021
Q2
$1K Buy
543
+166
+44% +$306 ﹤0.01% 6485
2021
Q1
$1K Sell
377
-48,533
-99% -$129K ﹤0.01% 6460
2020
Q4
$157K Buy
48,910
+48,562
+13,955% +$156K ﹤0.01% 5039
2020
Q3
$1K Sell
348
-260
-43% -$747 ﹤0.01% 5903
2020
Q2
$1K Buy
608
+158
+35% +$260 ﹤0.01% 5832
2020
Q1
$0 Buy
+450
New ﹤0.01% 6844
2019
Q3
Sell
-2,425
Closed -$2K 6497
2019
Q2
$2K Sell
2,425
-140,674
-98% -$116K ﹤0.01% 5756
2019
Q1
$138K Sell
143,099
-14,070
-9% -$13.6K ﹤0.01% 4929
2018
Q4
$115K Buy
157,169
+102,605
+188% +$75.1K ﹤0.01% 4995
2018
Q3
$118K Buy
54,564
+1,335
+3% +$2.89K ﹤0.01% 5059
2018
Q2
$265K Buy
53,229
+24,966
+88% +$124K ﹤0.01% 4727
2018
Q1
$111K Buy
28,263
+231
+0.8% +$907 ﹤0.01% 5032
2017
Q4
$75K Buy
+28,032
New +$75K ﹤0.01% 5168
2017
Q3
Sell
-23
Closed 6215
2017
Q2
$0 Sell
23
-2
-8% ﹤0.01% 6208
2017
Q1
$0 Hold
25
﹤0.01% 6208
2016
Q4
$0 Buy
25
+2
+9% ﹤0.01% 6232
2016
Q3
$0 Hold
23
﹤0.01% 6223
2016
Q2
$0 Sell
23
-6,847
-100% ﹤0.01% 6315
2016
Q1
$37K Sell
6,870
-957
-12% -$5.15K ﹤0.01% 5130
2015
Q4
$96K Sell
7,827
-19
-0.2% -$233 ﹤0.01% 4755
2015
Q3
$115K Sell
7,846
-1,102
-12% -$16.2K ﹤0.01% 4617
2015
Q2
$175K Buy
8,948
+5,160
+136% +$101K ﹤0.01% 4539
2015
Q1
$68K Buy
3,788
+3,166
+509% +$56.8K ﹤0.01% 4725
2014
Q4
$15K Buy
622
+5
+0.8% +$121 ﹤0.01% 5269
2014
Q3
$15K Sell
617
-337
-35% -$8.19K ﹤0.01% 5277
2014
Q2
$27K Buy
954
+754
+377% +$21.3K ﹤0.01% 5103
2014
Q1
$7K Buy
+200
New +$7K ﹤0.01% 5324